Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 9,030.00
-190.00 (-2.06%)
Oct 10, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 210.01 billion as of October 10, 2025. Its market cap has decreased by -35.59% in one year.
Market Cap
210.01B
Enterprise Value
171.97B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,030.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 210.01B, an increase of 31.06%. That is a compound annual growth rate of 5.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 214.43B | -10.59% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2,517.20B | 1,470.89% |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 579.68T |
| SK hynix | 273.06T |
| LG Energy Solution | 93.37T |
| Samsung Biologics | 71.81T |
| Hanwha Aerospace | 56.44T |
| Hyundai Motor Company | 48.05T |
| HD Hyundai Heavy Industries | 46.87T |
| KB Financial Group | 42.53T |